Lieberman JA - Search Results

1

Signaling pathways in schizophrenia: emerging targets and therapeutic strategies.

Karam CS, Ballon JS, Bivens NM, Freyberg Z, Girgis RR, Lizardi-Ortiz JE, Markx S, Lieberman JA, Javitch JA. Karam CS, et al. Among authors: lieberman ja. Trends Pharmacol Sci. 2010 Aug;31(8):381-90. doi: 10.1016/j.tips.2010.05.004. Epub 2010 Jun 25. Trends Pharmacol Sci. 2010. PMID: 20579747 Free PMC article. Review.

2

Molecular pathophysiology of metabolic effects of antipsychotic medications.

Ballon JS, Pajvani U, Freyberg Z, Leibel RL, Lieberman JA. Ballon JS, et al. Among authors: lieberman ja. Trends Endocrinol Metab. 2014 Nov;25(11):593-600. doi: 10.1016/j.tem.2014.07.004. Epub 2014 Sep 2. Trends Endocrinol Metab. 2014. PMID: 25190097 Review.

3

Clozapine v. chlorpromazine in treatment-naive, first-episode schizophrenia: 9-year outcomes of a randomised clinical trial.

Girgis RR, Phillips MR, Li X, Li K, Jiang H, Wu C, Duan N, Niu Y, Lieberman JA. Girgis RR, et al. Among authors: lieberman ja. Br J Psychiatry. 2011 Oct;199(4):281-8. doi: 10.1192/bjp.bp.110.081471. Br J Psychiatry. 2011. PMID: 21292928 Clinical Trial.

4

The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.

Goff DC, Falkai P, Fleischhacker WW, Girgis RR, Kahn RM, Uchida H, Zhao J, Lieberman JA. Goff DC, et al. Among authors: lieberman ja. Am J Psychiatry. 2017 Sep 1;174(9):840-849. doi: 10.1176/appi.ajp.2017.16091016. Epub 2017 May 5. Am J Psychiatry. 2017. PMID: 28472900 Review.

5

The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review.

Girgis RR, Zoghbi AW, Javitt DC, Lieberman JA. Girgis RR, et al. Among authors: lieberman ja. J Psychiatr Res. 2019 Jan;108:57-83. doi: 10.1016/j.jpsychires.2018.07.006. Epub 2018 Jul 21. J Psychiatr Res. 2019. PMID: 30055853 Review.

6

Early Detection and Preventive Intervention in Schizophrenia: From Fantasy to Reality.

Lieberman JA, Small SA, Girgis RR. Lieberman JA, et al. Am J Psychiatry. 2019 Oct 1;176(10):794-810. doi: 10.1176/appi.ajp.2019.19080865. Am J Psychiatry. 2019. PMID: 31569988 Review.

7

Anti-viral properties of antipsychotic medications in the time of COVID-19.

Girgis RR, Lieberman JA. Girgis RR, et al. Among authors: lieberman ja. Psychiatry Res. 2021 Jan;295:113626. doi: 10.1016/j.psychres.2020.113626. Epub 2020 Nov 30. Psychiatry Res. 2021. PMID: 33290940 Free PMC article. No abstract available.

8

Presynaptic regulation of dopamine transmission in schizophrenia.

Lyon GJ, Abi-Dargham A, Moore H, Lieberman JA, Javitch JA, Sulzer D. Lyon GJ, et al. Among authors: lieberman ja. Schizophr Bull. 2011 Jan;37(1):108-17. doi: 10.1093/schbul/sbp010. Epub 2009 Jun 12. Schizophr Bull. 2011. PMID: 19525353 Free PMC article.

9

Aripiprazole versus haloperidol treatment in early-stage schizophrenia.

Girgis RR, Merrill DB, Vorel SR, Edward Kim, Kimberly Portland, You M, Pikalov A, Whitehead R, Lieberman JA. Girgis RR, et al. Among authors: lieberman ja. J Psychiatr Res. 2011 Jun;45(6):756-62. doi: 10.1016/j.jpsychires.2010.09.003. Epub 2010 Oct 9. J Psychiatr Res. 2011. PMID: 20937506 Free PMC article. Clinical Trial.

10

A randomized exploratory trial of an α-7 nicotinic receptor agonist (TC-5619) for cognitive enhancement in schizophrenia.

Lieberman JA, Dunbar G, Segreti AC, Girgis RR, Seoane F, Beaver JS, Duan N, Hosford DA. Lieberman JA, et al. Neuropsychopharmacology. 2013 May;38(6):968-75. doi: 10.1038/npp.2012.259. Epub 2012 Dec 18. Neuropsychopharmacology. 2013. PMID: 23303043 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

791 results

Search Page